BRAF and melanoma: To the best of our knowledge, we show for the first time that ascorbate has a cytotoxic effect on explicitly BRAF mutant melanoma cells including cells with acquired resistance to the BRAF inhibitor vemurafenib or BRAFi/MEKi double resistant cells.